ANR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 43.51%

Insider Buying (Last 12 Months): A$0.00

Insider Selling (Last 12 Months): A$0.00

Anatara Lifesciences Insider Trading History Chart

Anatara Lifesciences Share Price & Price History

A^$0.00

+0.30 (1.20%)

As of 05/13/2020 01:00 AM ET

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

Anatara Lifesciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/11/2023	John Michailidis	Insider	Issued	250,000	A$0.02	A$5,500.00
12/8/2023	David Brookes	Insider	Issued	725,716	A$0.02	A$15,965.75
12/19/2022	David Brookes	Insider	Issued	857,143	A$0.04	A$32,571.43
12/16/2022	Jane Ryan	Insider	Issued	142,858	A$0.04	A$5,000.03
12/12/2022	David Brookes	Insider	Cancelled	65,658	A$0.04	A$2,298.03

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him

SEC Filings (Institutional Ownership Changes) for Anatara Lifesciences (ASX:ANR)

10.61% of Anatara Lifesciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry in water. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

3,950 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65

Who are the company insiders with the largest holdings of Anatara Lifesciences?: Anatara Lifesciences' top insider shareholders include:
David Brookes (Insider)
Jane Ryan (Insider)
John Michailidis (Insider)
Learn More about top insider investors at Anatara Lifesciences.